Earnings History Data for Day One Biopharmaceuticals, Inc. (DAWN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
24-02-2026	AH		DAWN	Day One Biopharmaceuticals, Inc.	1,210	N/A	-0.17	-0.69	Day One Biopharmaceuticals reports Q4 results [2/24/2026 4:05 PM]	12.02	0.32 (2.74%)	11.51	-0.51 (-4.24%)	5.64 - 13.20	1,978,105	1,690,000	78,296
Google finance search Google investor relations search SeekingAlpha Zacks Finviz CNBC Yahoo Finance MarketWatch Nasdaq quote StockTwits TradingView AlphaQuery InvestorPlace ChartMill Day One Biopharmaceuticals Q4 2025 Earnings Preview [2/23/2026 5:35 PM] Day One Biopharmaceuticals reports Q4 results [2/24/2026 4:05 PM] DAWN Chart by TradingView
04-11-2025	AH		DAWN	Day One Biopharmaceuticals, Inc.	762.09	-0.19	-0.28	0.38	Day One Biopharmaceuticals GAAP EPS of -$0.19 beats by $0.09, revenue of $39.8M beats by $1.97M [11/4/2025 4:01 PM]	9.20	1.90 (26.03%)	7.80	0.50 (6.85%)	5.64 - 16.76	9,848,512	1,720,000	25,285
Day One Biopharmaceuticals GAAP EPS of -$0.19 beats by $0.09, revenue of $39.8M beats by $1.97M [11/4/2025 4:01 PM] Day One raises 2025 revenue guidance to $145M–$150M as OJEMDA sees sustained double-digit growth [11/4/2025 8:37 PM] Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Report Preview: What To Expect [Nov-03-25 07:53AM]
05-08-2025	AH		DAWN	Day One Biopharmaceuticals, Inc.	674.06	-0.29	-0.35	-0.05	Day One Biopharmaceuticals GAAP EPS of -$0.29, revenue of $33.9M [8/5/2025 5:19 PM]	5.77	-1.12 (-16.21%)	5.92	-0.96 (-13.95%)	5.64 - 16.76	8,510,286	1,790,000	92,812
Day One Biopharmaceuticals GAAP EPS of -$0.29, revenue of $33.9M [8/5/2025 5:19 PM] Day One Biopharmaceuticals Non-GAAP EPS of -$0.29 beats by $0.05, revenue of $33.91M misses by $0.99M [8/5/2025 5:26 PM] Day One Biopharmaceuticals outlines $140M–$150M 2025 OJEMDA revenue target as new patient scripts accelerate [8/5/2025 9:20 PM] Earnings To Watch: Day One Biopharmaceuticals Inc (DAWN) Reports Q2 2025 Result [Aug-04-25 09:54AM]
06-05-2025	AH		DAWN	Day One Biopharmaceuticals, Inc.	803.74	-0.35	-0.46	-0.72	Day One Biopharmaceuticals GAAP EPS of -$0.35 beats by $0.09, revenue of $30.76M beats by $0.49M [5/6/2025 4:33 PM]	6.32	-0.67 (-9.66%)	7.05	0.06 (0.86%)	6.26 - 17.79	3,365,006	0	2,786
Day One Biopharmaceuticals GAAP EPS of -$0.35 beats by $0.09, revenue of $30.76M beats by $0.49M [5/6/2025 4:33 PM] Day one biopharmaceuticals highlights OJEMDA revenue growth and pipeline progress in Q1 2025 [5/6/2025 10:13 PM] Day One Reports First Quarter 2025 Financial Results and Corporate Progress [2025-05-06 04:01PM] Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Preview: What to Expect [May-05-25 10:00AM]
25-02-2025	AH		DAWN	Day One Biopharmaceuticals, Inc.	1,250	-0.69	-0.35	-0.64	Day One Biopharmaceuticals GAAP EPS of -$1.02 misses by $0.29, revenue of $131.16M beats by $8.64M [2/25/2025 4:52 PM]	9.86	-1.96 (-16.58%)	11.10	-0.72 (-6.09%)	9.77 - 18.07	3,073,796	740,000	3,664
Day One Biopharmaceuticals reports Q4 results [2/25/2025 4:11 PM] Day One Biopharmaceuticals GAAP EPS of -$1.02 misses by $0.29, revenue of $131.16M beats by $8.64M [2/25/2025 4:52 PM] Day One Biopharmaceuticals Inc (DAWN) Q4 2024 Earnings Report Preview: What To Look For [2025-02-25 01:36AM] Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress [2025-02-25 04:05PM]
30-10-2024	AH		DAWN	Day One Biopharmaceuticals, Inc.	1,420	0.38	-0.20	-0.54	Day One Biopharmaceuticals reports Q3 results [10/30/2024 4:08 PM]	14.71	0.24 (1.69%)	15.94	1.47 (10.16%)	10.90 - 18.07	3,591,118	850,000	57,994
Day One Biopharmaceuticals reports Q3 results [10/30/2024 4:08 PM] Day One Reports Third Quarter 2024 Financial Results and Corporate Progress [2024-10-30 04:01PM]
30-07-2024	PM		DAWN	Day One Biopharmaceuticals	1,401	-0.05	-0.67	0.00	Day One Biopharmaceuticals GAAP EPS of -$0.05, revenue of $8.19M [7/30/2024 9:35 AM]	15.12	-0.23 (-1.53%)	16.00	0.64 (4.17%)	9.67 - 18.07	2,945,034	900,000	33,834
Day One Biopharmaceuticals announces $175M private placement [7/30/2024 7:22 AM] Day One Biopharmaceuticals GAAP EPS of -$0.05, revenue of $8.19M [7/30/2024 9:35 AM]
26-02-2024	AH		DAWN	Day One Biopharmaceuticals	1,267	-0.64	-0.57	0.00	Day One Biopharmaceuticals reports Q4 results [2/26/2024 5:14 PM]	17.33	1.68 (10.73%)	15.99	0.34 (2.17%)	9.67 - 20.39	732,588	390,000	959
Day One Biopharmaceuticals reports Q4 results [2/26/2024 5:14 PM]
07-08-2023	AH		DAWN	Day One Biopharmaceuticals	946.00	-0.61	-0.60	0.00	Day One Biopharmaceuticals GAAP EPS of -$0.61 in-line [8/7/2023 5:39 PM]	13.09	0.72 (5.82%)	12.37	0.0 (0.00%)	10.84 - 28.35	457,368	640,000	10,656
Day One Biopharmaceuticals GAAP EPS of -$0.61 in-line [8/7/2023 5:39 PM]
01-05-2023	PM		DAWN	Day One Biopharmaceuticals	890.00	-0.59	-0.60	0.00		14.48	2.08 (16.77%)	0.0	0.0 (0.00%)	5.44 - 28.35	2,034,945	1,030,000	0

07-11-2022	AH		DAWN	Day One Biopharmaceuticals	1,423	-0.53	-0.53	0.00	Day One Biopharmaceuticals GAAP EPS of -$0.53 [11/7/2022 5:15 PM]	19.74	0.26 (1.33%)	19.48	0.0 (0.00%)	5.44 - 28.35	443,532	510,000	17,298
Day One Biopharmaceuticals GAAP EPS of -$0.53 [11/7/2022 5:15 PM] Day One Reports Third Quarter 2022 Financial Results and Corporate Progress [Nov-07-22 04:30PM]
04-08-2022	AH	4:30 PM ET (Aug 4)	DAWN	Day One Biopharmaceuticals	1,287	-0.60	-0.49	0.00	Day One Biopharmaceuticals GAAP EPS of -$0.60 [8/4/2022 5:43 PM]	23.64	3.19 (15.60%)	20.50	0.05 (0.24%)	5.44 - 28.70	928,658	350,000	685
Day One Biopharmaceuticals GAAP EPS of -$0.60 [8/4/2022 5:43 PM] Day One Reports Second Quarter 2022 Financial Results and Corporate Progress [Aug-04-22 04:30PM]
12-05-2022	AH		DAWN	Day One Biopharmaceuticals	475.00	-0.48	-0.39	0.00	Day One Biopharmaceuticals GAAP EPS of -$0.48 misses by $0.08 [5/12/2022 5:12 PM]	7.50	0.55 (7.91%)	6.95	0.0 (0.00%)	6.53 - 28.70	349,901	280,000	539
Day One Biopharmaceuticals GAAP EPS of -$0.48 misses by $0.08 [5/12/2022 5:12 PM] Day One Reports First Quarter 2022 Financial Results and Provides Business Update [May-12-22 04:30PM]
08-11-2021	AH		DAWN	Day One Biopharmaceuticals	1,608	-0.33	-0.28	0.00	Day One Biopharmaceuticals EPS misses by $0.07 [11/8/2021 5:22 PM]	23.73	-1.10 (-4.43%)	0.0	0.0 (0.00%)	17.19 - 28.70	43,988	60,000	0
Day One Biopharmaceuticals EPS misses by $0.07 [11/8/2021 5:22 PM] Day One Reports Third Quarter 2021 Financial Results and Corporate Progress [Nov-08-21 04:50PM]